ClinicalTrials.Veeva

Menu

Glucose Control in Open Heart Surgery

U

University of Sao Paulo

Status and phase

Completed
Phase 1

Conditions

Heart Valve Diseases
Ventricular Dysfunction
Hyperglycaemia During Perioperative Period

Treatments

Drug: human regular insulin

Study type

Interventional

Funder types

Other

Identifiers

NCT00370643
number: 637-02

Details and patient eligibility

About

The purpose of the study is to seek if there is difference to state glucose level in 80-120mg/dl or 200mg/dl in patients submitted to open heart surgery

Full description

Hyperglycaemia in the intensive care unit and perioperative period has been accused to be one of the causes of worse clinical outcome. It is known that in open heart surgeries the glucose level must be set less than 200mg/dl, but new trials had set the glucose level lower than that: 140mg/dl in some studies and even lower (80-110mg/dl). Our trial had the intention to seek if there is difference setting glucose level in 2 different ones would modifies clinical outcome.

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult more than 21 years old
  • open heart surgery with cardiopulmonary bypass

Exclusion criteria

  • renal dysfunction
  • reoperation
  • use of inotropic support
  • neurological dysfunction
  • chronic pulmonary obstructive disease
  • emergency or urgency

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems